EP1073332A4 - Compositions a base de r-rabeprazole et procedes - Google Patents

Compositions a base de r-rabeprazole et procedes

Info

Publication number
EP1073332A4
EP1073332A4 EP99921512A EP99921512A EP1073332A4 EP 1073332 A4 EP1073332 A4 EP 1073332A4 EP 99921512 A EP99921512 A EP 99921512A EP 99921512 A EP99921512 A EP 99921512A EP 1073332 A4 EP1073332 A4 EP 1073332A4
Authority
EP
European Patent Office
Prior art keywords
rabeprazole
compositions
methods
rabeprazole compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921512A
Other languages
German (de)
English (en)
Other versions
EP1073332A1 (fr
Inventor
William E Yelle
Paul D Rubin
Patrick Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP1073332A1 publication Critical patent/EP1073332A1/fr
Publication of EP1073332A4 publication Critical patent/EP1073332A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP99921512A 1998-04-30 1999-04-28 Compositions a base de r-rabeprazole et procedes Withdrawn EP1073332A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8372598P 1998-04-30 1998-04-30
US83725P 1998-04-30
PCT/US1999/009205 WO1999055157A1 (fr) 1998-04-30 1999-04-28 Compositions a base de r-rabeprazole et procedes

Publications (2)

Publication Number Publication Date
EP1073332A1 EP1073332A1 (fr) 2001-02-07
EP1073332A4 true EP1073332A4 (fr) 2005-06-15

Family

ID=22180277

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921512A Withdrawn EP1073332A4 (fr) 1998-04-30 1999-04-28 Compositions a base de r-rabeprazole et procedes

Country Status (5)

Country Link
EP (1) EP1073332A4 (fr)
JP (1) JP2002512262A (fr)
AU (1) AU3870599A (fr)
CA (1) CA2330139A1 (fr)
WO (1) WO1999055157A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359912A4 (fr) * 2000-06-19 2006-05-03 Eisai Co Ltd Nouvelles methodes utilisant des derives de pyridine
US8912337B2 (en) 2010-06-24 2014-12-16 Cipla Limited Salts and polymorphs of dexrabeprazole
CN105395490B (zh) * 2014-08-23 2018-04-03 南京海纳医药科技股份有限公司 一种含右旋雷贝拉唑钠药物组合物冻干粉针及其制备方法
WO2024075017A1 (fr) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition de calcification de valve aortique

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045552A (en) * 1986-11-13 1991-09-03 Eisai Co., Ltd. Pyridine derivatives having anti-ulcerative activity
JPH07278141A (ja) * 1994-01-12 1995-10-24 Eisai Co Ltd 光学活性ベンズイミダゾール誘導体の製造法および中間体
DE19801811A1 (de) * 1998-01-19 1999-07-22 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE9602442D0 (sv) * 1996-06-20 1996-06-20 Astra Ab Administration of pharmaceuticals

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045552A (en) * 1986-11-13 1991-09-03 Eisai Co., Ltd. Pyridine derivatives having anti-ulcerative activity
JPH07278141A (ja) * 1994-01-12 1995-10-24 Eisai Co Ltd 光学活性ベンズイミダゾール誘導体の製造法および中間体
DE19801811A1 (de) * 1998-01-19 1999-07-22 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002312211, retrieved from STN accession no. 2002:772730 Database accession no. 137:247700 *
DATABASE WPI Week 199601, Derwent World Patents Index; AN 1996-003307, XP002312212 *
MIGNON M ET AL: "Rabeprazole therapy effective in Zollinger-Ellison syndrome and idiopathic gastric acid hypersecretion", GUT, vol. 44, no. SUPPL. 1, April 1999 (1999-04-01), & BRITISH SOCIETY OF GASTROENTEROLOGY ANNUAL MEETING; GLASGOW, SCOTLAND, UK; MARCH 23-25, 1999, pages A125, XP008040883, ISSN: 0017-5749 *
NOCHI S ET AL: "PREPARATION AND ABSOLUTE CONFIGURATIONS OF OPTICAL ISOMERS OF SODIUM 2-[[4-(3-METHOXYPROPOXY)-3-METHYLPYRIDIN-2YLÜMETHYLSULFINYLÜ-1H-BENZI MIDAZOLE (E3810)", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN. TOKYO, JP, vol. 44, no. 10, October 1996 (1996-10-01), pages 1853 - 1857, XP009014313, ISSN: 0009-2363 *
PRAKASH A ET AL: "Rabeprazole.", DRUGS. FEB 1998, vol. 55, no. 2, February 1998 (1998-02-01), pages 261 - 267 ; dis, XP008040880, ISSN: 0012-6667 *
RICHARDSON P ET AL: "PROTON PUMP INHIBITORS. PHARMACOLOGY AND RATIONALE FOR USE IN GASTROINSTESTINAL DISORDERS", DRUGS, ADIS INTERNATIONAL LTD, AT, vol. 56, no. 3, 1998, pages 307 - 335, XP000960763, ISSN: 0012-6667 *
See also references of WO9955157A1 *
TAKAKUWA S ET AL: "Enantioselective high-performance liquid chromatographic assay for determination of the enantiomers of a new anti-ulcer agent, E3810, in Beagle dog plasma and rat plasma", JOURNAL OF CHROMATOGRAPHY B : BIOMEDICAL APPLICATIONS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 673, no. 1, 3 November 1995 (1995-11-03), pages 113 - 122, XP004043535, ISSN: 0378-4347 *

Also Published As

Publication number Publication date
EP1073332A1 (fr) 2001-02-07
AU3870599A (en) 1999-11-16
WO1999055157A1 (fr) 1999-11-04
CA2330139A1 (fr) 1999-11-04
JP2002512262A (ja) 2002-04-23

Similar Documents

Publication Publication Date Title
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB2348808B (en) Methods and compositions for desensitisation
EP1102535A4 (fr) Composes et procedes
EP1056456A4 (fr) Compositions et procedes d'utilisation du r-lansoprazole
GB9813271D0 (en) Composition and use
HUP0103562A3 (en) Novel compositions and use
BG105437A (en) REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM
GB9819979D0 (en) Sanitising compositions and methods
EP1056457A4 (fr) Compositions de s-lansoprazole et procedes d'utilisation
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
IL142635A0 (en) Compositions and methods using lactadherin or variants thereof
GB9806788D0 (en) Composition
EP1073333A4 (fr) Compositions a base de s-rabeprazole et procedes
GB9803506D0 (en) Composition and method
GB9803232D0 (en) Compound composition and use
EP1139981A4 (fr) Compositions et procedes d'utilisation associes
GB9814869D0 (en) Process and composition
EP1073332A4 (fr) Compositions a base de r-rabeprazole et procedes
GB9804041D0 (en) Composition
AU3900499A (en) (+)-hydroxyrisperidone compositions and methods
SG74707A1 (en) Cyclic bis-phosphites and compositions
GB9923979D0 (en) Sanitizing composition and method
GB9805172D0 (en) Composition and use
EP1066051A4 (fr) Scielline et utilisations de celle-ci
GB9921747D0 (en) Compositions and methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 17/06 B

Ipc: 7A 61P 1/04 B

Ipc: 7A 61K 31/4439 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050425

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20070212